Promising Outcomes from Gene Therapy for Rare Deafness
A recent study highlights the potential of gene therapy to restore hearing in individuals with a rare genetic form of deafness, showing effects that may last over two years.
Editorial Staff
1 min read
Updated 17 days ago
Researchers have reported significant advancements in gene therapy aimed at treating a rare type of genetic deafness, with some patients regaining their hearing.
The therapy has reportedly enabled both children and adults, including those up to 32 years old, to hear for the first time, with benefits lasting beyond two years for certain individuals.
This development could represent a major breakthrough in medical research and healthcare for those affected by this specific form of deafness.